Fitzgerald Joseph Michael's Form 4 filing
Boston Scientific Corp (BSX) · filed Nov 4, 2025
- Accession no.
- 0001225208-25-008911
- Filed
- Nov 4, 2025
- Trade date
- Nov 3, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $4.97M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Fitzgerald Joseph MichaelCIK 0001484186 | Officer (EVP & Group Pres, Cardiology) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 3, 2025 | Common Stock | MOption exerciseAcquired | +50,000 | $26.15 | +$1,307,500 | 228,342 | Direct | |
| Nov 3, 2025 | Common Stock | SSaleDisposed | −3,600 | $100.75 | −$362,700 | 224,742 | Direct | |
| Nov 3, 2025 | Common Stock | SSaleDisposed | −16,928 | $99.76 | −$1,688,737.28 | 207,814 | Direct | |
| Nov 3, 2025 | Common Stock | SSaleDisposed | −29,472 | $99.14 | −$2,921,854.08 | 178,342 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 3, 2025 | Common Stock | MOption exerciseDisposed | −50,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.